{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319557540352.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.lfs.2017.11.030"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0024320517306070?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0024320517306070?httpAccept=text/plain"}}],"dc:title":[{"@value":"The regulation of FOXO1 and its role in disease progression"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319557540356","@type":"Researcher","foaf:name":[{"@value":"Ya-qi Xing"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319557540357","@type":"Researcher","foaf:name":[{"@value":"Ang Li"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319557540352","@type":"Researcher","foaf:name":[{"@value":"Yang Yang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319557540353","@type":"Researcher","foaf:name":[{"@value":"Xiao-xia Li"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319557540354","@type":"Researcher","foaf:name":[{"@value":"Li-nan Zhang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319557540355","@type":"Researcher","foaf:name":[{"@value":"Hui-cai Guo"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00243205"}],"prism:publicationName":[{"@value":"Life Sciences"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2018-01","prism:volume":"193","prism:startingPage":"124","prism:endingPage":"131"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0024320517306070?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0024320517306070?httpAccept=text/plain"}],"createdAt":"2017-11-20","modifiedAt":"2018-08-25","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360021389823406976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1/Th17 immune response"}]},{"@id":"https://cir.nii.ac.jp/crid/1360866730492611072","@type":"Article","resourceType":"preprint","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1/Th17 immune response"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694366531834496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Silencing FOXO1 attenuates dexamethasone-induced apoptosis in osteoblastic MC3T3-E1 cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1390014183322866304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anticancer Activity of Methyl Protodioscin against Prostate Cancer by Modulation of Cholesterol-Associated MAPK Signaling Pathway <i>via</i> FOXO1 Induction"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.lfs.2017.11.030"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2019.04.112_references_DOI_IUc0E6xIdPMuTcpZpm9ITLmzuIC"},{"@type":"CROSSREF","@value":"10.1038/s41598-023-34211-x_references_DOI_IUc0E6xIdPMuTcpZpm9ITLmzuIC"},{"@type":"CROSSREF","@value":"10.1248/bpb.b22-00682_references_DOI_IUc0E6xIdPMuTcpZpm9ITLmzuIC"},{"@type":"CROSSREF","@value":"10.21203/rs.3.rs-2153766/v1_references_DOI_IUc0E6xIdPMuTcpZpm9ITLmzuIC"}]}